tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Soligenix’s dusquetide granted Orphan Drug Designation in Behcet’s Disease
PremiumThe FlySoligenix’s dusquetide granted Orphan Drug Designation in Behcet’s Disease
1M ago
Soligenix Faces Nasdaq Non-Compliance Notice
Premium
Company Announcements
Soligenix Faces Nasdaq Non-Compliance Notice
1M ago
Soligenix receives FDA orphan designation for dusquetide
Premium
The Fly
Soligenix receives FDA orphan designation for dusquetide
2M ago
Soligenix’s Phase 3 Study on HyBryte for CTCL: Key Insights for Investors
PremiumCompany AnnouncementsSoligenix’s Phase 3 Study on HyBryte for CTCL: Key Insights for Investors
2M ago
Soligenix’s SGX945 shows efficacy in Phase 2 Behcet’s Disease trial
Premium
The Fly
Soligenix’s SGX945 shows efficacy in Phase 2 Behcet’s Disease trial
2M ago
Soligenix price target lowered to $6 from $10 at Alliance Global Partners
Premium
The Fly
Soligenix price target lowered to $6 from $10 at Alliance Global Partners
3M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
6M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
6M ago
Soligenix reports interim results from study of HyBryte
Premium
The Fly
Soligenix reports interim results from study of HyBryte
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100